CClinicalTrials.gg
CompletedNCT02554617FeNO_norUpdated May 3, 2016

Measurements of Exhaled Nitric Oxide in Healthy Subjects in Thailand

An observational study in Normal Non-fluency, sponsored by Mahidol University. Completed at 1 site in Thailand. Open to participants aged 6 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-05-03.

Sponsored by Mahidol University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
100
Ages
6 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to determine fractional exhaled nitric oxide (FeNO) level in healthy subjects among Thai populations.

Read the detailed description

Fractional exhaled nitric oxide (FeNO) were produced from epithelial cells of inflammatory airways and eosinophils and this gas was discovered since 1991.

Fractional exhaled nitric oxide (FeNO) has direct association with severity of inflammation of bronchial trees and sputum eosinophils and use for additional investigation for diagnosis asthma or inflammatory airway diseases.

There are many factors from previous studies that associate with level of fractional exhaled nitric oxide (FeNO), one of that factors is race therefore we can't use level from another studies with different race for use as reference and there is no study about level of fractional exhaled nitric oxide in Thai population.

It is therefore desirable to examine level of fractional exhaled nitric oxide (FeNO) in healthy subjects among Thai population and will be the main objective of this research.

02

Conditions studied

  • Normal Non-fluency

Keywords

  • healthy people
  • fractional exhaled nitric oxide (FeNo)
  • factors
03

In context

Lead sponsor

Mahidol University is the lead sponsor of 731 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

community sample

Inclusion criteria

  • healthy subjects in community

Exclusion criteria

Exclusion Criteria:

  • smoker or past history of smoking
  • asthma, allergic rhinitis, chronic respiratory disease or other chronic illness
  • history of wheezing within 12 months before enrollment
  • history of upper or lower respiratory tract infection within 6 weeks before enrollment
  • drink ethanol within 48 hours before enrollment
  • drink caffeine within day before enrollment
  • during pregnancy
  • chronic use of any drugs
  • participate other project within 30 days
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
06

What researchers measure

Primary outcomes

  1. fractional exhaled nitric oxide level

    Time frame: 10 minutes (average time ), on the day of enrollment

07

Study locations

1 site
  • Siriraj Hospital
    Bangkok, 10700, Thailand
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02554617
Lead sponsor
Mahidol University
Responsible party
Nualanong Visitsunthorn (Professor, Mahidol University) — Principal investigator
First posted
Sep 18, 2015
Start date
Oct 2010
Primary completion
Jun 2015
Completion
Aug 2015
Last update
May 3, 2016

Study contacts

Professor Nualanong Visitsunthorn, MD
principal investigator · Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion